Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

ZIOP

|Includes:ZIOPHARM Oncology, Inc. (ZIOP)

Interesting price action. Perhaps the short covering issue will finally come into play. Short interest remains robust.

Definately some institutional accumulation going on judging by the end of day prints.


Early SCLC data is next inflection point. Likely due out very late 2011.


Stocks: ZIOP